Partnership

The DAO Institute collaborates with partners in the pharmaceutical, biotechnology, and nutrition sectors to advance research, clinical application, and awareness of DAO Deficiency. We offer structured collaboration pathways that support clinical studies, translational research programs, professional education, and patient-focused initiatives.
Our goal is to facilitate evidence-based innovation by integrating scientific expertise, clinical insight, and technological infrastructure. Collaboration opportunities include participation in clinical trial networks, co-development of diagnostic and therapeutic tools, sponsorship of educational or research programs, and joint efforts to expand access to specialized care.
We welcome discussions with organizations committed to scientific rigor, healthcare impact, and the responsible advancement of solutions that improve the quality of life of individuals affected by DAO Deficiency.